Targeting mitochondrial dysfunction to quell neuroinflammation in central nervous system (CNS): a new strategy for treating CNS disease with nanomedicines is a research paper published in Science Bulletin (2026). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Central South University
Grant: 2023QYJC017
Natural Science Foundation of Ningxia Province
Grant: 2022AAC02058
National Natural Science Foundation of China
Grant: 82373871
National Natural Science Foundation of China
Grant: 82574405
Xiangya Hospital, Central South University
Grant: 2023LNJ12
Key Research and Development Program of Hunan Province of China
MeSH Terms
Keywords